Results 201 to 210 of about 240,351 (245)

Pediatric health: mechanistic insights into inflammatory diseases and emerging therapeutic pathway-targeted approaches. [PDF]

Transl Pediatr
Zhou Q, Lai C, Zhang M, Li R, Li K, He W.   +5 more
europepmc   +1 more source

When Infection Meets Inflammation: <i>Listeria monocytogenes</i> and Host Signaling Pathways. [PDF]

Biology (Basel)
Jia Y, Yang K, Guo R, Ding K, Wang S, Chen S.   +5 more
europepmc   +1 more source

Psoriatic Arthritis: Therapeutic Advances and Novel Treatment Strategies-A Scoping Review. [PDF]

Life (Basel)
Athanassiou L, Kostoglou-Athanassiou I, Kaiafa G, Savopoulos C, Shoenfeld Y, Athanassiou P.   +5 more
europepmc   +1 more source

The Immunologic Paradox of BTK Inhibitors in Chronic Lymphocytic Leukemia: Selectivity, Hypogammaglobulinemia, and Infection Risk. [PDF]

Cancers (Basel)
Andreescu M, Tudorache SI, Moldovan CA, Moldovan AD, Cochior D, Popov V, Andreescu B, Ionescu D, Padurariu-Covit MD.   +8 more
europepmc   +1 more source

Biologic therapy in geriatric psoriasis: 6-month real-world data on PASI, inflammatory indices, and hepatitis B/tuberculosis safety. [PDF]

Biomol Biomed
Ünal E, Pakırdaşı B, Emre S, Yücel MB, Celik B, Özbek EN, Gedikli N, Avcı A, Ertaş R, Yıldız O.   +9 more
europepmc   +1 more source

Review on the Mechanism of and Therapies Targeting PANoptosis in Ulcerative Colitis. [PDF]

Biomolecules
Zhao M, Liu M, Tian W, Ren T, Jing J, Zheng Y, Chen Z.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Curcumin: An Effective Inhibitor of Interleukin-6

Current Pharmaceutical Design, 2017
Curcumin is apolyphenolic compound found in the dietary spice turmeric. Anti-inflammatory effects of turmeric have been known for centuries and extensive studies over the last two to three decades revealed that curcumin is a key component in the anti-inflammatory effects of turmeric. Chronic inflammation is involved in the various pathologic states and
Morteza, Ghandadi, Amirhossein, Sahebkar
openaire   +2 more sources

Interleukin-6 inhibitors

2020
Abstract Interleukin 6 (IL-6) is a pleiotropic cytokine which has diverse biological activity, with wide-ranging effects on the immune system, homeostasis, and metabolism. It is the most abundant pro-inflammatory cytokine in the synovial joints and sera of patients with active rheumatoid arthritis (RA) and has been found to play a ...
Neelam Hassan, Ernest Choy
openaire   +1 more source

Interleukin-6 Inhibitor: Tocilizumab

2015
Inhibitors of interleukin-6 (IL-6) are proteins which decrease the actions of the inflammatory cytokine, IL-6. Clinically, tocilizumab is the major inhibitor of IL-6. Several other proteins with IL-6 inhibitory actions (e.g., sirukumab) are being tested in clinical trials.
Pile, Kevin D., Graham, Garry G., Mahler, Stephen M.   +2 more
openaire   +5 more sources